Risk Factors for Septic Shock After Irinotecan-Containing Chemotherapy: An Exploratory Case-Control Study.

Maki UmemiyaYoshihide Inayama Eiji NakataniKenta ItoMitsuru TsujiTeruki YoshidaSae YuRei GouNaoki HorikawaHirohiko TaniKenzo Kosaka

Published in: Drugs in R&D (2022)

Medical personnel involved in cancer therapy should consider the possible risk of septic shock developing due to neutropenic enterocolitis when administering irinotecan-containing chemotherapy in patients with a history of pelvic irradiation.

Keyphrases

septic shock
cancer therapy
locally advanced
rectal cancer
healthcare
drug delivery
squamous cell carcinoma
low birth weight
chemotherapy induced